Identification of the metalloproteinase stromelysin in the physis

Abstract

For long bone growth to occur, calcification of the matrix must commence in the lower hypertrophic zone of the growth plate. It is generally accepted that physeal proteoglycans help regulate mineralization, and that at least in vitro, intact proteoglycans can inhibit mineralization. Thus degradation of proteoglycan may be a necessary step prior to calcification. Previous work in o u r laboratory has demonstrated the presence of neutral metallo-proteases in the growth plate with highest levels in the hypertrophic zone, where calcification occurs.Stromelysin (MMP-3) is a connective tissue matrix-degrading enzyme. It was formerly known as proteoglycanase and is generally considered to be one of the major proteoglycan degrading enzymes in cartilage. Stromelysin is implicated in cartilage destruction in osteoarthritis and may also be involved in tissue remodeling in the physis. Our goal was to determine if the neutral protease previously reported by the authors in the physis was stromelysin.In this study we used Western blots and antibodies to stromelysin and to the stromelysin cleavage site in aggrecan, the most common form of proteoglycan, to demonstrate the presence of stromelysin in the bovine physis. When an antibody raised against the stromelysin cleavage site of aggrecan (FVDIPEN) was incubated with a Western blot, which had been run with aggrecan extracted from bovine physes, a positive reaction resulted. This suggests that there is stromelysin degradation in vivo in the physis. Two different polyclonal antibodies to stromelysin gave positive results on Western blots of purified media from growth plate cultures indicating that stromelysin is produced in vitro in culture. These antibodies also reacted with active stromelysin.The presence of stromelysin in the physis implicates it in physeal physiology. The concentration of its activity in the lower hypertrophic zone and zone of provisional calcification suggests that it may be particularly important in mineralization. 0 3002 Orthopaedic Research Society. Published by

Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage

“…Conceivably, remodeling of the growing cartilage requires only MMP-3, but not MMP-9, MMP-13, or ADAMTS-4. This inference is supported by reports that MMP-3 modulates remodeling in the physis of calves 19 and in articular and proliferating chondrocytes of fetal rabbits. 20 On the other hand, it is possible that low concentrations of inflammatory cytokines in the synovium of this spastic quadriplegia patient activated MMP-3 more than the other degradative enzymes.…”

Involvement of matrix metalloproteinases in the growth plate response to physiological mechanical load

“…MMP-3 is the most potent proteoglycanase among all MMPs; it has broad substrate specificity, including proteoglycans, casein, fibronectin, and collagens type III, IV, and V (1,58). We show that, unlike MMP-2 and -9, MMP-3 is highly expressed in the hypertrophic chondrocytes.…”

Developmental Mechanisms in Articular Cartilage Degradation in Osteoarthritis

“…They produce long columns of flattened cells and express hyaline ECM similar to resting zone chondrocytes. The space for the cells newly formed in the course of cell division is generated by the matrix-degrading activity of collagenases MMP-13, MT1-MMP [46, 47], and other MMPs such as MMP-3 [48]. These cells also express proliferation-specific growth factors, namely, TGF β 1–3, FGF-2 [35, 43, 49, 50], PTHrP, insulin growth factor (IGF-) I and II [35, 51–53], a cell death inhibitor that regulates apoptosis Bcl-2 (B-cell lymphoma-2) [54], and transcription factor Sox9 (SRY-type high-mobility-group box transcription factor 9) [35, 55].…”